How Does Vitamin D Affect Musculoskeletal Health?

A Widespread Deficiency

Vitamin D deficiency is among the most prevalent nutritional insufficiencies in the developed world. Estimates vary by population and definition, but rates of clinically significant deficiency (serum 25-hydroxyvitamin D below 30nmol/L) range from 20–40% in many Western countries, with rates of insufficiency (below 50nmol/L) considerably higher. The primary cause is inadequate sun exposure — the skin's ultraviolet-B-mediated synthesis of vitamin D from 7-dehydrocholesterol is the dominant source for most people, and modern indoor-predominant lifestyles, high-latitude living, and routine sun protection dramatically reduce this synthesis. Dietary sources contribute modestly at best. The musculoskeletal consequences of this widespread deficiency are substantial and clinically underappreciated.

Vitamin D and Bone Health

The relationship between vitamin D and bone health is the most well-characterised of its musculoskeletal roles. Vitamin D is required for intestinal absorption of calcium and phosphate — the primary minerals of bone mineral density. In deficiency states, intestinal calcium absorption falls by 30–40%, stimulating secondary hyperparathyroidism that mobilises calcium from bone to maintain serum calcium within the narrow physiological range. The result of prolonged deficiency is progressive demineralisation of bone — osteomalacia in severe deficiency, and a significant independent contributor to osteoporosis risk in chronic insufficiency. Vitamin D insufficiency is also associated with impaired fracture healing, as the calcification of provisional callus requires adequate vitamin D-mediated calcium availability. Supplementation to achieve sufficiency is among the most evidence-supported interventions for osteoporosis prevention and fracture risk reduction.

Vitamin D and Muscle Function

Vitamin D receptors (VDRs) are expressed in skeletal muscle cells, and vitamin D signalling directly influences muscle protein synthesis, satellite cell proliferation, mitochondrial function, and the fast-twitch to slow-twitch fibre ratio. Vitamin D deficiency is associated with measurable reductions in muscle strength and power, particularly in the fast-twitch (Type II) fibres responsible for force-generating capacity and rapid postural reactions. Clinically, vitamin D deficiency presents with proximal muscle weakness — difficulty rising from a chair, climbing stairs, or reaching overhead — that may be mistakenly attributed to ageing or deconditioning rather than a correctable nutritional deficit. Meta-analyses of randomised controlled trials demonstrate that vitamin D supplementation in deficient older adults significantly improves lower limb muscle strength and reduces fall rates — one of the most impactful public health interventions available for this population.

Vitamin D and Connective Tissue

Vitamin D receptors are expressed on tenocytes and ligament fibroblasts, and observational research consistently finds associations between vitamin D deficiency and tendon injury rates in athletic populations. Several mechanisms have been proposed: vitamin D may regulate tenocyte collagen synthesis and matrix metalloproteinase activity; it modulates the inflammatory environment of healing tendons through its effects on macrophage and T-cell function; and it may influence the mechanical properties of tendon collagen through effects on cross-link formation. While the randomised controlled trial evidence for supplementation specifically improving tendon outcomes is less developed than for bone and muscle, the biological plausibility and consistent observational associations support vitamin D sufficiency as a component of comprehensive tendon and ligament management.

Vitamin D Deficiency and Pain

The relationship between vitamin D deficiency and musculoskeletal pain is clinically important and mechanistically supported. Vitamin D receptors are expressed on neurons, and vitamin D signalling modulates neuronal excitability, nociceptor sensitivity, and the production of neurotrophins that influence pain processing. Cross-sectional studies consistently find higher rates of vitamin D deficiency in chronic pain populations — including fibromyalgia, chronic low back pain, and widespread musculoskeletal pain — than in pain-free controls. Intervention trials in deficient patients have demonstrated pain reduction following supplementation to sufficiency, though the effect sizes are modest and most pronounced in patients with severe deficiency. Vitamin D testing should be routine in patients presenting with unexplained, diffuse, or treatment-refractory musculoskeletal pain.

Testing and Optimal Levels

Vitamin D status is measured as serum 25-hydroxyvitamin D (25-OHD) — the stable, circulating storage form. Deficiency is defined as below 30nmol/L (12ng/mL); insufficiency as 30–50nmol/L (12–20ng/mL); sufficiency as 50–125nmol/L (20–50ng/mL). For musculoskeletal health, most authorities recommend targeting the higher end of the sufficiency range — 75–125nmol/L (30–50ng/mL). Levels above 125nmol/L carry risk of toxicity (hypercalcaemia) and should be avoided. Testing is indicated in individuals with risk factors for deficiency: limited sun exposure, darker skin pigmentation, obesity, older age, malabsorption conditions, or unexplained musculoskeletal symptoms.

Dietary and Supplementation Sources

Dietary sources of vitamin D — oily fish, egg yolks, fortified dairy and plant milks — contribute modestly to status, typically providing 200–400IU/day, which is insufficient to maintain sufficiency in the absence of adequate sun exposure. Supplementation is required for most deficient individuals. A daily dose of 1000–2000IU of vitamin D3 (cholecalciferol — more effective than D2/ergocalciferol) is appropriate for maintenance in adults without deficiency; loading doses of 3000–5000IU daily for eight to twelve weeks may be required to restore sufficiency from a deficient state, ideally guided by repeat testing. Vitamin D is fat-soluble and best absorbed when taken with a meal containing fat.